Erratum: Down syndrome: Genes, model systems, and progress towards pharmacotherapies and clinical trials for cognitive deficits (Cytogenetic and Genome Research (2013) 141 (260-271) DOI: 10.1159/000354306);Down syndrome: Genes, model systems, and progress towards pharmacotherapies and clinical trials for cognitive deficits

Cytogenetic and Genome Research

Volumn 141, Issue 4, 2013, Pages 260-271

  Busciglio, J ^a   Capone, G ^b   O'Byran, J P ^c   Gardiner, K J ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Chromosome HSA21; Cognition; Down syndrome; Gene function; Mouse models; Trisomy

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CYSTATIN B; DUAL SPECIFICITY YAK1 RELATED KINASE 1A; HIGH MOBILITY GROUP N1 PROTEIN; INTERSECTIN; INTERSECTIN 1; MEMANTINE; PROTEIN; PROTEIN KINASE; PROTEIN S100B; SYNJ1 PROTEIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL M2; UNCLASSIFIED DRUG;

AUTISM; CAENORHABDITIS ELEGANS; CHROMOSOME 21; CLINICAL TRIAL (TOPIC); COGNITION; COGNITIVE DEFECT; CONFERENCE PAPER; DISOMY; DOWN SYNDROME; DRUG THERAPY; FRAGILE X SYNDROME; HUMAN; HUMAN GENETICS; IMMUNE SYSTEM; INTELLECTUAL IMPAIRMENT; METABOLOMICS; MITOCHONDRION; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRISOMY; ZEBRA FISH; ANIMAL; COGNITION DISORDERS; DISEASE MODEL; DRUG EFFECTS; GENETICS; INTELLECTUAL DISABILITY; MOUSE; NEURAL STEM CELL;

CAENORHABDITIS ELEGANS; DANIO RERIO; MUS;

ANIMALS; CHROMOSOMES, HUMAN, PAIR 21; COGNITION; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; DOWN SYNDROME; HUMANS; INTELLECTUAL DISABILITY; MICE; NEURAL STEM CELLS;

EID: 84887102747     PISSN: 14248581     EISSN: 1424859X     Source Type: Journal    
DOI: 10.1159/000356560     Document Type: Erratum

References (26)

1. Abuhatzira L, Shamir A, Schones DE, Schaffer AA, Bustin M: The chromatin-binding protein HMGN1 regulates the expression of methyl CpG-binding protein 2 (MECP2) and affects the behavior of mice. J Biol Chem 286: 42051-42062 (2011).
2. Ahmed MM, Dhanasekaran AR, Tong S, Wiseman FK, Fisher EM, et al: Protein profiles in Tc1 mice implicate novel pathway perturbations in the Down syndrome brain. Hum Mol Genet 22: 1709-1724 (2013).
3. Bianchi P, Ciani E, Guidi S, Trazzi S, Felice D, et al: Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome. J Neurosci 30: 8769-8779 (2010).
4. Ceru S, Konjar S, Maher K, Repnik U, Krizaj I, et al: Stefin B interacts with histones and cathepsin L in the nucleus. J Biol Chem 285: 10078-10086 (2010).
5. Cossec JC, Lavaur J, Berman DE, Rivals I, Hoischen A, et al: Trisomy for synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes. Hum Mol Genet 21: 3156-3172 (2012).
6. Ding X, Sanchez DJ, Shahangian A, Al-Shyoukh I, Cheng G, Ho CM: Cascade search for HSV-1 combinatorial drugs with high antiviral efficacy and low toxicity. Int J Nanomedicine 7: 2281-2292 (2012).
7. Duchon A, Raveau M, Chevalier C, Nalesso V, Sharp AJ, Herault Y: Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling Down syndrome. Mamm Genome 22: 674-684 (2011).
8. Gribble SM, Wiseman FK, Clayton S, Prigmore E, Langley E, et al: Massively parallel sequencing reveals the complex structure of an irradiated human chromosome on a mouse background in the Tc1 model of Down syndrome. PLoS One 8:e60482 (2013).
9. Herault Y, Duchon A, Velot E, Marechal D, Brault V: The in vivo Down syndrome genomic library in mouse. Prog Brain Res 197: 169-197 (2012).
10. Hunter MP, Nelson M, Kurzer M, Wang X, Kryscio RJ, et al: Intersectin 1 contributes to phenotypes in vivo: implications for Down's syndrome. Neuroreport 22: 767-772 (2011).
11. Li LB, Chang KH, Wang PR, Hirata RK, Papayannopoulou T, Russell DW: Trisomy correction in Down syndrome induced pluripotent stem cells. Cell Stem Cell 11: 615-619 (2012).
12. Martinez-Cue C, Martinez P, Rueda N, Vidal R, Garcia S, et al: Reducing GABA A ?5 receptormediated inhibition rescues functional and neuromorphological deficits in a mouse model of Down syndrome. J Neurosci 33: 3953-3966 (2013).
13. Pereira PL, Magnol L, Sahun I, Brault V, Duchon A, et al: A new mouse model for the trisomy of the Abcg1-U2af1 region reveals the complexity of the combinatorial genetic code of Down syndrome. Hum Mol Genet 18: 4756-4769 (2009).
14. Russo A, O'Bryan JP: Intersectin 1 is required for neuroblastoma tumorigenesis. Oncogene 31: 4828-4834 (2012).
15. Schupf N, Zigman WB, Tang MX, Pang D, Mayeux R, et al: Change in plasma A? peptides and onset of dementia in adults with Down syndrome. Neurology 75: 1639-1644 (2010).
16. Shapiro LA, Bialowas-McGoey LA, Whitaker-Azmitia PM: Effects of S100B on serotonergic plasticity and neuroinflammation in the hippocampus in Down syndrome and Alzheimer's disease: studies in an S100B overexpressing mouse model. Cardiovasc Psychiatry Neurol 2010:pii153657 (2010).
17. Sosa LJ, Bergman J, Estrada-Bernal A, Glorioso TJ, Kittelson JM, Pfenninger KH: Amyloid precursor protein is an autonomous growth cone adhesion molecule engaged in contact guidance. PLoS One 8:e64521 (2013).
18. Sturgeon X, Gardiner KJ: Transcript catalogs of human chromosome 21 and orthologous chimpanzee and mouse regions. Mamm Genome 22: 261-271 (2011).
19. Virji-Babul N, Moiseev A, Moiseeva N, Sun W, Ribary U, Lott I: Altered brain dynamics during voluntary movement in individuals with Down syndrome. Neuroreport 22: 358-364 (2011).
20. Virji-Babul N, Watt K, Nathoo F, Johnson P: Recognition of facial expressions of emotion in adults with Down syndrome. Phys Occup Ther Pediatr 32: 333-343 (2012).
21. Virji-Babul N, Moiseev A, Sun W, Feng T, Moiseeva N, et al: Neural correlates of music recognition in Down syndrome. Brain Cogn 81: 256-262 (2013).
22. Weick JP, Held DL, Bonadurer GF 3rd, Doers ME, Liu Y, et al: Deficits in human trisomy 21 iPSCs and neurons. Proc Natl Acad Sci USA 110: 9962-9967 (2013).
23. Wilming LG, Gilbert JG, Howe K, Trevanion S, Hubbard T, Harrow JL: The vertebrate genome annotation (Vega) database. Nucleic Acids Res 36 (Database issue):D753-760 (2008).
24. Xie YF, Belrose JC, Lei G, Tymianski M, Mori Y, et al: Dependence of NMDA/GSK-3? mediated metaplasticity on TRPM2 channels at hippocampal CA3-CA1 synapses. Mol Brain 4: 44 (2011).
25. Yang DS, Stavrides P, Mohan PS, Kaushik S, Kumar A, et al: Therapeutic effects of remediating autophagy failure in a mouse model of Alzheimer disease by enhancing lysosomal proteolysis. Autophagy 7: 788-789 (2011).
26. Yu T, Liu C, Belichenko P, Clapcote SJ, Li S, et al: Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice. Brain Res 1366: 162-171 (2010).